A chance to change the paradigm of outcome assessment of antimicrobial stewardship programs

Clinical Infectious Diseases

Volumn 61, Issue 5, 2015, Pages 807-808

  Molina, Jose ^a   Cisneros, Jose M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antimicrobial stewardship programs; Assessment; Bacterial resistance; Outcome

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; DRUG EFFICACY; DRUG SAFETY; EXTERNAL VALIDITY; HOSPITAL ADMINISTRATOR; HOSPITAL READMISSION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); CLINICAL TRIAL (TOPIC); METHODOLOGY;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE, BACTERIAL; HUMANS; RESEARCH DESIGN;

EID: 84942039473     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ496     Document Type: Note

References (8)

1. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2013;4:CD003543.
2. McGowan JE. Antimicrobial stewardship-the state of the art in 2011: focus on outcome and methods. Infect Control Hosp Epidemiol 2012; 33:331-7.
3. Nagel JL, Stevenson JG, Eiland EH, Kaye KS. Demonstrating the value of antimicrobial stewardship programs to hospital administrators. Clin Infect Dis 2014; 59(suppl 3):S146-53.
4. McGregor JC, Furuno JP. Optimizing research methods used for the evaluation of antimicrobial stewardship programs. Clin Infect Dis 2014; 59(suppl 3):S185-92.
5. Llewelyn MJ, Hand K, Hopkins S, Walker AS. Antibiotic policies in acute English NHS trusts: implementation of "Start Smart-Then Focus" and relationship with Clostridium difficile infection rates. J Antimicrob Chemother 2015; 70:1230-5.
6. Bell S, Davey P, Nathwani D, et al. Risk of AKI with gentamicin as surgical prophylaxis. J Am Soc Nephrol 2014; 25:2625-32.
7. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280:1233-7.
8. Evans SR, Rubin D, Follmann D, et al. Desirability of outcome ranking (DOOR) and response adjusted for days of antibiotic risk (RADAR). Clin Infect Dis 2015; 61:800-6.